One80 Intermediaries Expands Offerings for Allied Health Care With the Acquisition of Manchester Specialty Programs

BOSTON–(BUSINESS WIRE)–One80 Intermediaries (One80), a specialty insurance broker headquartered in Boston, today announced that it has acquired Manchester Specialty Programs. Terms of the deal were not disclosed. Manchester Specialty Programs (Manchester Specialty) provides comprehensive business insurance solutions for home care, medical staffing, allied health, and human/social services organizations. Coverage is available on a national basis, with a specialist underwriting and marketing ap

National Pre-Roll Brand, Toast, Elevates Michigan Cannabis Market Through Manufacturing Partnership  

ASPEN, Colo.–(BUSINESS WIRE)–Toast, a leading multi-state pre-roll brand in the cannabis industry, is thrilled to announce its partnership with 42 Degrees Processing, a respected manufacturer and distributor in the Michigan market. With this partnership, Toast will launch a selection of their cannabis pre-rolls throughout Michigan. Originating in Aspen, Colorado, Toast is a premium cannabis brand that has been crafting exceptional pre-rolls since 2017. Toast sets themselves apart in the marke

Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, announced today new research detailing the first-ever isolation of a novel indolethylamine N-methyltransferase from cane toad (Rhinella marina) and the successful development of a bioproduction platform for the isolation and pharmacological s

University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA-approved clinical trial for Post-Traumatic Stress Disorder (PTSD)

OMAHA, Neb. & GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. today announced that the first patient has been enrolled in an FDA-approved clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology, for Post-Traumatic Stress Disorder (PTSD). (Clinical Trials.gov Identifier NCT05269459) The trial is being led by principal investigator Matthe

HEXO to Host Second Quarter 2023 Earnings Conference Call

GATINEAU, Québec–(BUSINESS WIRE)–HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”), a leading producer of high-quality cannabis products, announced today that it will hold an audio only conference call on March 17, 2023, at 10 a.m. EDT, to review its financial results for the second fiscal quarter, ended January 31, 2023. The results will be released after market close on Thursday, March 16, 2023. Following the prepared remarks, there will be a question-and-answer session. Charli

Organigram Provides Edison JOLTS Product Update

TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced that it has received notification from Health Canada that Health Canada has determined that certain Jolts lozenge products in their 100 mg THC per package format (the “Products”) have been improperly classified as an “extract” rather than an “edible” under the Cannabis Regulations. The Company launched the Products in August 2021 following significant research, development and r

Hercules Capital Business Update and Response to the Closure of Silicon Valley Bank

PALO ALTO, Calif.–(BUSINESS WIRE)–The team at Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”) is working collectively with our employees, stockholders, stakeholders, bondholders, rating agencies, portfolio companies, and our portfolio companies’ venture capital and private equity sponsors to navigate the challenges created by the FDIC’s decision to place Silicon Valley Bank (“SVB”) under receivership. We are vigilantly monitoring this evolving situation and are fully committ

Kanabo Group Launches ‘Treat It’ – UK’s First Online Medicinal Cannabis Clinic For Chronic Pain Management

LONDON–(BUSINESS WIRE)–Kanabo Group today announced the launch of Treat It the UK’s first online medical cannabis clinic for pain management. Treat It solves the problem faced by millions of chronic pain sufferers in the UK whose conventional pharmaceutical treatments are not working or are frustrated by long wait times to be referred for treatment. Built on a unique health tech platform, which accesses the patient’s medical record, Treat It is able to provide high-quality treatments quickly

gamma and Entertainment Icon Snoop Dogg Announce Today’s Arrival of the Death Row Records Catalog to All Streaming Services Worldwide

LOS ANGELES–(BUSINESS WIRE)–gamma and Snoop Dogg celebrate today’s arrival of the Death Row Records catalog, inclusive of music and videos, to all streaming services worldwide. This partnership is designed as a long-term licensing agreement which provides gamma with the exclusive worldwide rights to market and distribute the Death Row Records catalog. Vydia, recently acquired by gamma, will distribute the music exclusively. Additionally, gamma will also release two new albums from Snoop Dogg

Haymarket Media Acquires the American Journal of Endocannabinoid Medicine

NEW YORK–(BUSINESS WIRE)–Haymarket Media, Inc. is pleased to announce that it has acquired the American Journal of Endocannabinoid Medicine (AJEM)—a peer-reviewed journal focused on cannabinoid medicine. Haymarket is making an additional investment in AJEM to increase its engagement with healthcare professionals (HCPs) and fulfill its mission to educate and inform the medical community on cannabinoid-based therapy. Physicians are not trained in the endocannabinoid system (ECS) in medical scho